FRIESON RON bought AKBA
June 17, 2026 · Form 4 insider transaction
FRIESON RON bought 53,600 shares of Akebia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
53,600
Price
$0.00
Total value
N/A
InsiderFRIESON RON
RoleDirector
SecurityStock Option (Right to buy)
Transaction codeA: Grant or award
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after53,600
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.